Major Pharmaceuticals recalls 10mg ChlorproMAZINE tablets due to impurity risk
Major Pharmaceuticals recalls 10mg ChlorproMAZINE Hydrochloride Tablets with N-Nitroso-Desmethyl Chlorpromazine impurity above safety limits. Rx-only medication distributed in cartons of 100 tablets.
Recall notice
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
Contact the company
What happened, in plain English
Major Pharmaceuticals is recalling 10mg ChlorproMAZINE Hydrochloride Tablets because they contain an impurity that exceeds safety limits. This could pose a health risk if taken as directed. Read more at govinfonow.com/recall/32148-major-pharmaceuticals-recalls-10mg-chlorpromazine-tablets-due-to-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32148-major-pharmaceuticals-recalls-10mg-chlorpromazine-tablets-due-to-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0366-2025
Cite this page
“Major Pharmaceuticals recalls 10mg ChlorproMAZINE tablets due to impurity risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32148-major-pharmaceuticals-recalls-10mg-chlorpromazine-tablets-due-to-impurity-risk. Based on FDA recall #D-0366-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0366-2025%22&limit=1).
Why it’s dangerous
The tablets contain N-Nitroso-Desmethyl Chlorpromazine impurity levels above the recommended safety limit. This impurity could potentially cause health issues when taken as prescribed.
Who’s affected
People who have prescription ChlorproMAZINE Hydrochloride Tablets from Major Pharmaceuticals. Those with medical conditions requiring this medication are most at risk.
How to tell if you have this one
Check for 10mg ChlorproMAZINE Hydrochloride Tablets in cartons of 100 tablets (10x10). The product was distributed by Major Pharmaceuticals with NDC 0904-7129-61 and Lot# N02114.
- Brand
Major Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the product name, dosage, and packaging details to confirm if it matches the recalled items.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 9 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0366-2025 (April 14, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0366-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.